AUPH

Aurinia Pharmaceuticals Inc.

Insider trading activity for Aurinia Pharmaceuticals Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.

Past 3 months

-$546.4K

net selling

Bought(0 · 0 insiders): $0
Sold(2 · 1 insiders): $546.4K

Past 6 months

+$11.9M

net buying

Bought(5 · 1 insiders): $12.5M
Sold(2 · 1 insiders): $546.4K

Past 12 months

+$24.6M

net buying

Bought(11 · 1 insiders): $25.1M
Sold(2 · 1 insiders): $546.4K

Transaction history

The 61 most recent Form 4 transactions.

Open in screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Sep 10	Robertson Stephen P.	Chief Legal Officer	SSELL	11,939	$15.95	$190.4K	-2.0%	Open the original filing on SEC.gov
Aug 21	Robertson Stephen P.	Chief Legal Officer	SSELL	20,975	$16.97	$355.9K	-3.4%	Open the original filing on SEC.gov
Jun 4	Goetz Kathleen	Director	AGRANT◆	23,931	—	—	—	Open the original filing on SEC.gov
Jun 4	Bailey Jeffrey Allen	Director	AGRANT◆	23,931	—	—	—	Open the original filing on SEC.gov
Jun 4	Johnson Craig A	Director	AGRANT◆	23,931	—	—	—	Open the original filing on SEC.gov
Jun 4	Nova Tina Susan	Director	AGRANT◆	23,931	—	—	—	Open the original filing on SEC.gov
Jun 2	Tang Kevin	Chief Executive Officer	JOTHER◆	10,000	$1.65	$16.5K	—	Open the original filing on SEC.gov
Jun 2	Tang Kevin	Chief Executive Officer	PBUY	206,005	$15.28	$3.1M	+1.6%	Open the original filing on SEC.gov
Jun 1	Tang Kevin	Chief Executive Officer	PBUY	99	$15.34	$1.5K	0.0%	Open the original filing on SEC.gov
Jun 1	Tang Kevin	Chief Executive Officer	PBUY	343,521	$15.28	$5.2M	+2.8%	Open the original filing on SEC.gov
May 29	Tang Kevin	Chief Executive Officer	PBUY	262,682	$15.31	$4M	+2.1%	Open the original filing on SEC.gov
May 29	Tang Kevin	Chief Executive Officer	PBUY	2,299	$15.35	$35.3K	+<0.1%	Open the original filing on SEC.gov
May 18	Cole Ryan	Chief Operating Officer	AGRANT◆	70,230	—	—	—	Open the original filing on SEC.gov
May 18	Cole Ryan	Chief Operating Officer	AGRANT	116,144	—	—	—	Open the original filing on SEC.gov
May 18	Robertson Stephen P.	Chief Legal Officer	AGRANT	115,541	—	—	+22.8%	Open the original filing on SEC.gov
May 18	Hearne Michael S	Chief Financial Officer	AGRANT◆	70,230	—	—	—	Open the original filing on SEC.gov
May 18	Hearne Michael S	Chief Financial Officer	AGRANT	116,144	—	—	—	Open the original filing on SEC.gov
Mar 6	Keenan Greg	SVP, Chief Medical…	FTAX	8,069	$14.32	$115.5K	-5.0%	Open the original filing on SEC.gov
Mar 3	Tang Kevin	Director	PBUY	184,208	$14.22	$2.6M	+1.5%	Open the original filing on SEC.gov
Mar 2	Miller Joseph M	Chief Financial Officer	FTAX	37,511	$14.21	$533K	-6.1%	Open the original filing on SEC.gov
Mar 2	Donley Matthew Maxwell	Chief Operating Officer	FTAX	40,761	$14.21	$579.2K	-5.7%	Open the original filing on SEC.gov
Mar 2	Greenleaf Peter	Chief Executive Officer	FTAX	100,890	$14.21	$1.4M	-5.2%	Open the original filing on SEC.gov
Mar 2	Robertson Stephen P.	EVP, General Counsel	FTAX	36,525	$14.21	$519K	-6.7%	Open the original filing on SEC.gov
Mar 2	Tang Kevin	Director	PBUY	115,792	$14.21	$1.6M	+1.0%	Open the original filing on SEC.gov
Mar 2	Tang Kevin	Director	PBUY	83,561	$14.33	$1.2M	+0.7%	Open the original filing on SEC.gov
Feb 27	Miller Joseph M	Chief Financial Officer	AGRANT◆	95,700	—	—	—	Open the original filing on SEC.gov
Feb 27	Miller Joseph M	Chief Financial Officer	AGRANT	57,229	—	—	+10.3%	Open the original filing on SEC.gov
Feb 27	Donley Matthew Maxwell	Chief Operating Officer	AGRANT◆	97,256	—	—	—	Open the original filing on SEC.gov
Feb 27	Donley Matthew Maxwell	Chief Operating Officer	AGRANT	58,160	—	—	+8.8%	Open the original filing on SEC.gov
Feb 27	Greenleaf Peter	Chief Executive Officer	AGRANT◆	328,424	—	—	—	Open the original filing on SEC.gov
Feb 27	Greenleaf Peter	Chief Executive Officer	AGRANT	196,403	—	—	+11.3%	Open the original filing on SEC.gov
Feb 27	Keenan Greg	SVP, Chief Medical…	AGRANT◆	67,870	—	—	—	Open the original filing on SEC.gov
Feb 27	Keenan Greg	SVP, Chief Medical…	AGRANT	40,586	—	—	+33.3%	Open the original filing on SEC.gov
Feb 27	Robertson Stephen P.	EVP, General Counsel	AGRANT◆	98,813	—	—	—	Open the original filing on SEC.gov
Feb 27	Robertson Stephen P.	EVP, General Counsel	AGRANT	59,090	—	—	+12.2%	Open the original filing on SEC.gov
Feb 27	Tang Kevin	Director	PBUY	1,600	$14.38	$23K	+<0.1%	Open the original filing on SEC.gov
Feb 27	Tang Kevin	Director	PBUY	214,839	$14.12	$3M	+1.8%	Open the original filing on SEC.gov
Feb 27	Tang Kevin	Director	PBUY	300,000	$13.90	$4.2M	+2.6%	Open the original filing on SEC.gov
Feb 20	Robertson Stephen P.	EVP, General Counsel	FTAX	34,638	$14.40	$498.8K	-6.7%	Open the original filing on SEC.gov
Feb 20	Miller Joseph M	Chief Financial Officer	FTAX	32,424	$14.40	$466.9K	-5.5%	Open the original filing on SEC.gov
Feb 20	Donley Matthew Maxwell	Chief Operating Officer	FTAX	32,901	$14.40	$473.8K	-4.7%	Open the original filing on SEC.gov
Feb 20	Greenleaf Peter	Chief Executive Officer	FTAX	100,171	$14.40	$1.4M	-5.4%	Open the original filing on SEC.gov
Feb 2	Keenan Greg	SVP, Chief Medical…	FTAX	11,552	$14.53	$167.9K	-8.6%	Open the original filing on SEC.gov
Jan 2	Robertson Stephen P.	EVP, General Counsel	FTAX	40,385	$15.95	$644.1K	-7.2%	Open the original filing on SEC.gov
Jan 2	Robertson Stephen P.	EVP, General Counsel	AGRANT	48,558	—	—	+9.5%	Open the original filing on SEC.gov
Jan 2	Donley Matthew Maxwell	Chief Operating Officer	FTAX	42,787	$15.95	$682.5K	-5.8%	Open the original filing on SEC.gov
Jan 2	Donley Matthew Maxwell	Chief Operating Officer	AGRANT	54,166	—	—	+8.0%	Open the original filing on SEC.gov
Jan 2	Miller Joseph M	Chief Financial Officer	FTAX	40,161	$15.95	$640.6K	-6.4%	Open the original filing on SEC.gov
Jan 2	Miller Joseph M	Chief Financial Officer	AGRANT	49,038	—	—	+8.5%	Open the original filing on SEC.gov
Jan 2	Greenleaf Peter	Chief Executive Officer	FTAX	113,169	$15.95	$1.8M	-5.8%	Open the original filing on SEC.gov
Jan 2	Greenleaf Peter	Chief Executive Officer	AGRANT	165,384	—	—	+9.2%	Open the original filing on SEC.gov
Nov 21, 2025	Bailey Jeffrey Allen	Director	FTAX	2,716	$15.68	$42.6K	-10.7%	Open the original filing on SEC.gov
Nov 21, 2025	Johnson Craig A	Director	FTAX	6,039	$15.68	$94.7K	-29.3%	Open the original filing on SEC.gov
Aug 5, 2025	Tang Kevin	Director	PBUY	200,000	$11.68	$2.3M	+1.8%	Open the original filing on SEC.gov
Aug 4, 2025	Tang Kevin	Director	PBUY	100,000	$11.34	$1.1M	+0.9%	Open the original filing on SEC.gov
Aug 1, 2025	Keenan Greg	Chief Medical Officer	SSELL	20,000	$10.50	$210K	-13.0%	Open the original filing on SEC.gov
Aug 1, 2025	Tang Kevin	Director	PBUY	1M	$10.12	$10.1M	+10.0%	Open the original filing on SEC.gov
May 16, 2025	Nova Tina Susan	Director	AGRANT◆	63,724	—	—	—	Open the original filing on SEC.gov
May 16, 2025	Johnson Craig A	Director	AGRANT◆	37,485	—	—	—	Open the original filing on SEC.gov
May 16, 2025	Goetz Kathleen	Director	AGRANT◆	63,724	—	—	—	Open the original filing on SEC.gov
May 16, 2025	Bailey Jeffrey Allen	Director	AGRANT◆	37,485	—	—	—	Open the original filing on SEC.gov

SSELL$190.4K

Robertson Stephen P. · Chief Legal…Sep 10

11,939 sh @ $15.95 · -2.0% own

SSELL$355.9K

Robertson Stephen P. · Chief Legal…Aug 21

20,975 sh @ $16.97 · -3.4% own

AGRANT◆—

Goetz Kathleen · DirectorJun 4

23,931 sh

AGRANT◆—

Bailey Jeffrey Allen · DirectorJun 4

23,931 sh

AGRANT◆—

Johnson Craig A · DirectorJun 4

23,931 sh

AGRANT◆—

Nova Tina Susan · DirectorJun 4

23,931 sh

JOTHER◆$16.5K

Tang Kevin · Chief Executive…Jun 2

10,000 sh @ $1.65

PBUY$3.1M

Tang Kevin · Chief Executive…Jun 2

206,005 sh @ $15.28 · +1.6% own

PBUY$1.5K

Tang Kevin · Chief Executive…Jun 1

99 sh @ $15.34 · 0.0% own

PBUY$5.2M

Tang Kevin · Chief Executive…Jun 1

343,521 sh @ $15.28 · +2.8% own

PBUY$4M

Tang Kevin · Chief Executive…May 29

262,682 sh @ $15.31 · +2.1% own

PBUY$35.3K

Tang Kevin · Chief Executive…May 29

2,299 sh @ $15.35 · +<0.1% own

AGRANT◆—

Cole Ryan · Chief Operating…May 18

70,230 sh

AGRANT—

Cole Ryan · Chief Operating…May 18

116,144 sh

AGRANT—

Robertson Stephen P. · Chief Legal…May 18

115,541 sh · +22.8% own

AGRANT◆—

Hearne Michael S · Chief Financial…May 18

70,230 sh

AGRANT—

Hearne Michael S · Chief Financial…May 18

116,144 sh

FTAX$115.5K

Keenan Greg · SVP, Chief Medical…Mar 6

8,069 sh @ $14.32 · -5.0% own

PBUY$2.6M

Tang Kevin · DirectorMar 3

184,208 sh @ $14.22 · +1.5% own

FTAX$533K

Miller Joseph M · Chief Financial…Mar 2

37,511 sh @ $14.21 · -6.1% own

FTAX$579.2K

Donley Matthew Maxwell · Chief Operating…Mar 2

40,761 sh @ $14.21 · -5.7% own

FTAX$1.4M

Greenleaf Peter · Chief Executive…Mar 2

100,890 sh @ $14.21 · -5.2% own

FTAX$519K

Robertson Stephen P. · EVP, General…Mar 2

36,525 sh @ $14.21 · -6.7% own

PBUY$1.6M

Tang Kevin · DirectorMar 2

115,792 sh @ $14.21 · +1.0% own

PBUY$1.2M

Tang Kevin · DirectorMar 2

83,561 sh @ $14.33 · +0.7% own

AGRANT◆—

Miller Joseph M · Chief Financial…Feb 27

95,700 sh

AGRANT—

Miller Joseph M · Chief Financial…Feb 27

57,229 sh · +10.3% own

AGRANT◆—

Donley Matthew Maxwell · Chief Operating…Feb 27

97,256 sh

AGRANT—

Donley Matthew Maxwell · Chief Operating…Feb 27

58,160 sh · +8.8% own

AGRANT◆—

Greenleaf Peter · Chief Executive…Feb 27

328,424 sh

AGRANT—

Greenleaf Peter · Chief Executive…Feb 27

196,403 sh · +11.3% own

AGRANT◆—

Keenan Greg · SVP, Chief Medical…Feb 27

67,870 sh

AGRANT—

Keenan Greg · SVP, Chief Medical…Feb 27

40,586 sh · +33.3% own

AGRANT◆—

Robertson Stephen P. · EVP, General…Feb 27

98,813 sh

AGRANT—

Robertson Stephen P. · EVP, General…Feb 27

59,090 sh · +12.2% own

PBUY$23K

Tang Kevin · DirectorFeb 27

1,600 sh @ $14.38 · +<0.1% own

PBUY$3M

Tang Kevin · DirectorFeb 27

214,839 sh @ $14.12 · +1.8% own

PBUY$4.2M

Tang Kevin · DirectorFeb 27

300,000 sh @ $13.90 · +2.6% own

FTAX$498.8K

Robertson Stephen P. · EVP, General…Feb 20

34,638 sh @ $14.40 · -6.7% own

FTAX$466.9K

Miller Joseph M · Chief Financial…Feb 20

32,424 sh @ $14.40 · -5.5% own

FTAX$473.8K

Donley Matthew Maxwell · Chief Operating…Feb 20

32,901 sh @ $14.40 · -4.7% own

FTAX$1.4M

Greenleaf Peter · Chief Executive…Feb 20

100,171 sh @ $14.40 · -5.4% own

FTAX$167.9K

Keenan Greg · SVP, Chief Medical…Feb 2

11,552 sh @ $14.53 · -8.6% own

FTAX$644.1K

Robertson Stephen P. · EVP, General…Jan 2

40,385 sh @ $15.95 · -7.2% own

AGRANT—

Robertson Stephen P. · EVP, General…Jan 2

48,558 sh · +9.5% own

FTAX$682.5K

Donley Matthew Maxwell · Chief Operating…Jan 2

42,787 sh @ $15.95 · -5.8% own

AGRANT—

Donley Matthew Maxwell · Chief Operating…Jan 2

54,166 sh · +8.0% own

FTAX$640.6K

Miller Joseph M · Chief Financial…Jan 2

40,161 sh @ $15.95 · -6.4% own

AGRANT—

Miller Joseph M · Chief Financial…Jan 2

49,038 sh · +8.5% own

FTAX$1.8M

Greenleaf Peter · Chief Executive…Jan 2

113,169 sh @ $15.95 · -5.8% own

AGRANT—

Greenleaf Peter · Chief Executive…Jan 2

165,384 sh · +9.2% own

FTAX$42.6K

Bailey Jeffrey Allen · DirectorNov 21, 2025

2,716 sh @ $15.68 · -10.7% own

FTAX$94.7K

Johnson Craig A · DirectorNov 21, 2025

6,039 sh @ $15.68 · -29.3% own

PBUY$2.3M

Tang Kevin · DirectorAug 5, 2025

200,000 sh @ $11.68 · +1.8% own

PBUY$1.1M

Tang Kevin · DirectorAug 4, 2025

100,000 sh @ $11.34 · +0.9% own

SSELL$210K

Keenan Greg · Chief Medical…Aug 1, 2025

20,000 sh @ $10.50 · -13.0% own

PBUY$10.1M

Tang Kevin · DirectorAug 1, 2025

1M sh @ $10.12 · +10.0% own

AGRANT◆—

Nova Tina Susan · DirectorMay 16, 2025

63,724 sh

AGRANT◆—

Johnson Craig A · DirectorMay 16, 2025

37,485 sh

AGRANT◆—

Goetz Kathleen · DirectorMay 16, 2025

63,724 sh

AGRANT◆—

Bailey Jeffrey Allen · DirectorMay 16, 2025

37,485 sh

Filing record

How quickly insiders here report their trades. Section 16 allows two business days from the transaction.

All 30 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Insiders at this company

Everyone who has filed a Form 4 for this issuer.

More biotech & pharma companies

Other issuers in the same industry with insider filings on record.

Whole sector →